Clinical safety and efficacy of the first-in-class Rho kinase inhibitor for lowering IOP: netarsudil and the fixed-dose combination of netarsudil and latanoprost “Novel surgical methods for addressing glaucoma” has been added to your cart. View cart €15.00 Clinical safety and efficacy of the first-in-class Rho kinase inhibitor for lowering IOP: netarsudil and the fixed-dose combination of netarsudil and latanoprost quantity Add to cart Category: Articles Tag: Volume 3 Description Description Authors: Janet B. Serle, Jake Radell Related products Family studies of primary open-angle glaucoma €15.00 Add to cart Laser alteration of the collector channels ostia. Pivotal paradigm shift from laser photocoagulation to laser photostimulation €15.00 Add to cart Special consideration for pediatric glaucoma €15.00 Add to cart The multiple-hit theory on the pathogenesis of primary open-angle glaucoma €15.00 Add to cart